TransMedics (TMDX) Income from Continuing Operations (2018 - 2026)
TransMedics (TMDX) recorded quarterly Income from Continuing Operations of 7315000.0 in Q1 2026, down 60.63% quarter-over-quarter from 18581000.0 in Q4 2025, and down 71.51% on a YoY basis from 25676000.0 in Q1 2025.
TransMedics (TMDX) Income from Continuing Operations (2018 - 2026) Analysis & Trends
TransMedics' Income from Continuing Operations history runs 9 years deep, the most recent figure standing at 7315000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 71.51% year-over-year to 7315000.0; the TTM figure through Mar 2026 stood at 85109000.0 (up 73.13% YoY), while the FY2025 annual figure was 83939000.0, up 135.26% from the prior year.
- Income from Continuing Operations was 7315000.0 for Q1 2026 at TransMedics, down from 18581000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 34882000.0 in Q2 2025 to a low of 25422000.0 in Q3 2023.
- Historically, Income from Continuing Operations has averaged 6504470.59 across 5 years, with a median of 7073000.0 in 2024.
- The sharpest annual moves came in 2023 and 2024: Income from Continuing Operations tumbled 242.34% in 2023, then jumped 1318.18% in 2024.
- A 5-year view of Income from Continuing Operations shows it stood at 6720000.0 in 2022, then soared by 537.51% to 29401000.0 in 2023, then plunged by 75.94% to 7073000.0 in 2024, then soared by 162.7% to 18581000.0 in 2025, then plunged by 60.63% to 7315000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 7315000.0 (Q1 2026), 18581000.0 (Q4 2025), and 24331000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | TransMedics | 2.72 Bn | 2.26 Bn | 101.16 Mn | 7.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.32 Mn |
| Dec 31, 2025 | 18.58 Mn |
| Sep 30, 2025 | 24.33 Mn |
| Jun 30, 2025 | 34.88 Mn |
| Mar 31, 2025 | 25.68 Mn |
| Dec 31, 2024 | 7.07 Mn |
| Sep 30, 2024 | 4.22 Mn |
| Jun 30, 2024 | 12.19 Mn |
| Mar 31, 2024 | 12.20 Mn |
| Dec 31, 2023 | 29.40 Mn |
| Sep 30, 2023 | -25.42 Mn |
| Jun 30, 2023 | -1.00 Mn |
| Mar 31, 2023 | -2.64 Mn |
| Dec 31, 2022 | -6.72 Mn |
| Sep 30, 2022 | -7.43 Mn |
| Jun 30, 2022 | -11.52 Mn |
| Mar 31, 2022 | -10.56 Mn |
| Dec 31, 2021 | 31.65 Mn |
| Sep 30, 2021 | -12.96 Mn |
| Jun 30, 2021 | -10.67 Mn |